Assessment of the Effectiveness, Socio-economic Impact and Implementation of a Digital Solution for Severe Patients

NACompletedINTERVENTIONAL
Enrollment

185

Participants

Timeline

Start Date

February 1, 2023

Primary Completion Date

July 31, 2024

Study Completion Date

September 15, 2024

Conditions
Heart Failure NYHA Class IIIHeart Failure NYHA Class IVChronic Obstructive Pulmonary Disease Severe
Interventions
OTHER

ADLIFE intervention

"The ADLIFE toolbox will be deployed, used and evaluated in seven healthcare environments to demonstrate the effectiveness of the ADLIFE intervention in clinical real conditions. Patients participating in ADLIFE will have a personalised care plan, created in the ADLIFE toolbox, developed and managed together with their healthcare professionals. PCPMP will be used within clinical sites´ ICT systems to create patient care plans based on most recent clinical data, following clinical evidence. The main task of patients and informal caregivers will be to use the ADLIFE toolbox as part of their healthcare process together with their healthcare professionals.~Patients recruited will use the ADLIFE system during the pilot study for a follow-up period between 3 and 12 months."

Trial Locations (7)

5000

Odense University Hospital, Odense

37269

Gesunder Werra-Meißner-Kreis GmbH, Eschwege

7744142

Maccabi Healthcare Services Southern Region, Ashdod

7747629

Assuta Ashdod Hospital, Ashdod

01006

Osakidetza, Vitoria-Gasteiz

CV2 2DX

UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS Trust, Coventry

Unknown

NHS Lanarkshire, Glasgow

All Listed Sponsors
collaborator

NHS Lanarkshire

OTHER_GOV

collaborator

Odense University Hospital

OTHER

collaborator

Assuta Ashdod Hospital

OTHER

collaborator

University Hospitals Coventry and Warwickshire NHS Trust

OTHER

collaborator

Gesunder Werra-Meißner-Kreis GmbH

UNKNOWN

collaborator

Maccabi Healthcare Services, Israel

OTHER

collaborator

Osakidetza

OTHER

lead

Biosistemak Institute for Health Systems Research

OTHER